Tag: Cannabis ⋅ Page 1

Professor Gely presents at ABA labor and employment law meeting

Professor Rafael Gely recently served as the Scholar in Residence for the 2020 mid-winter meeting of the of the ADR in Labor & Employment Law Committee (ABA Section of Labor and Employment Law).  In that capacity, Professor Gely presented two papers: (1) The Media’s Impact on The Perceptions of Arbitration (with Timothy D. Chandler, Louisiana State University); and (2) Ethics…

Professor Lietzan continues to write about the FDA regulation of CBD products

In a recent editorial for Drug Discovery Today, “A special exception for CBD in foods and supplements?”, Professor Erika Lietzan and co-author Patricia J. Zettler,  write about the emerging cannabidiol (CBD) market. They explain that most foods and dietary supplements containing CBD – even CBD from hemp — violate FDA’s “drug exclusion rules.” FDA has not been taking enforcement action,…

Professor Lietzan Quoted in Article about CBD

Professor Erika Lietzan was quoted recently in a Philadelphia Inquirer story, “Selling CBD in food is illegal, FDA says. So why are so many retailers selling it?,” about the sale of foods and dietary supplements containing CBD, or cannabidiol, which is derived from cannabis. CBD is reputed to have health benefits, and after FDA approved a new drug containing CBD in…

Professor Lietzan Presents at Symposium on Federal Regulation of Cannabis

Professor Erika Lietzan presented her most recently completed article at a symposium on federal regulation of cannabis. The symposium, hosted by the Food and Drug Law Institute, convened academics, scientists from the Food and Drug Administration, lawyers from private practice, and industry developing cannabis-based products, to consider the path forward for a federal regulatory regime. Professor Lietzan’s forthcoming article in the American…